• / Free eNewsletters & Magazine
  • / My Account
Home>Paul Larson

Paul Larson

  1. All
  2. Morningstar Articles
  3. Videos
  4. Investing
  1. The Market Is Richly Valued--Should You Worry?

    Although a drawdown in the short term is a real possibility, investors should still see a 4.5% to 6% real return over the long run, says Morningstar's Matt Coffina.

  2. A Rare, Wide-Moat Find in a Market With Few Values

    Investors concerned with Express Scripts' integration of Medco are overlooking the firm's long-term potential to benefit from an increased focus on health-care cost-cutting, says Morningstar StockInvestor editor Matt Coffina.

  3. A Few Picks to Tide Over the Bargain-Hunters

    In a fully valued market, there are worse things than buying wide-moat names at decent discounts.

  4. Larson's Strategies for Excess Returns

    StockInvestor editor Paul Larson discusses the importance of investing in companies that can compound their intrinsic values, buying on the cheap, avoiding stop-loss orders, and more.

  5. A Good Month for Quality Job Growth

    Morningstar's Bob Johnson sees the addition of jobs in the higher-paying sectors and a stable hours-worked metric as good signs for the labor market.

  6. How to Protect From Black Swans and Black Boxes

    The financial crisis proved that tumultuous events can and do happen, and investors need to keep a long-term perspective in a market that is incredibly short-term focused, says StockInvestor editor Paul Larson .

  7. A Rare Time for Wide-Moat Stocks?

    StockInvestor editor Paul Larson details recent changes to Morningstar's Wide Moat Focus Index, noting how the rally in wide-moat names could have them more fairly priced than lower-quality stocks.

  8. Visa's Growth Story Is Not Broken

    Recent decelerating revenue growth has disappointed investors but is a temporary phenomenon, says Morningstar StockInvestor editor Matt Coffina.

  9. MLPs: High-Quality Income Generators

    Tax advantages and economic moats allow master limited partnerships to offer investors much more than just high yields, says Morningstar's Paul Larson .

  10. New Year, New Moat Ratings for These Stocks

    Competitive advantages improved for one health-care firm, while a spin-off at another narrowed its moat, says Morningstar's Paul Larson in his discussion on recent moat-rating upgrades and downgrades.

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.